These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine. Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361 [TBL] [Abstract][Full Text] [Related]
4. [Ambulatory treatment of hemorrhagic incidents in hemophiliacs with cryoprecipitate]. Lisichkov T; Angelova Ts Vutr Boles; 1973; 12(3):96-9. PubMed ID: 4543117 [No Abstract] [Full Text] [Related]
5. Suggestions for the management of factor VIII inhibitors. Rubinger M; Rivard GE; Teitel J; Walker H; Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269 [No Abstract] [Full Text] [Related]
6. Treatment of hemorrhage in hemophilia. Med Lett Drugs Ther; 1967 Apr; 9(8):31-2. PubMed ID: 6040171 [No Abstract] [Full Text] [Related]
7. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies. Blatt PM; Ménaché D; Roberts HR Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386 [TBL] [Abstract][Full Text] [Related]
9. [Development of inhibitors against factor VIII in patients with hemophilia A]. Cohn J; Nielsen VG Nord Med; 1971; 86(49):1495. PubMed ID: 5137039 [No Abstract] [Full Text] [Related]
10. [A rational substitution therapy of hemorrhage in hemophilia]. Malaska Z; Kubícek IR; Wiedermannová A Vnitr Lek; 1970 Jan; 16(1):34-40. PubMed ID: 5416235 [No Abstract] [Full Text] [Related]
11. Cryoprecipitate--a new product for the control of bleeding in haemophilic patients. Grobbelaar BG; Clyde JH; Seimon L S Afr Med J; 1967 Feb; 41(5):91-2. PubMed ID: 6021085 [No Abstract] [Full Text] [Related]
12. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia. Lange D; Lazerson J Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446 [No Abstract] [Full Text] [Related]
13. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Kessler CM; Ludlam CA Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193 [No Abstract] [Full Text] [Related]
14. Antibodies to factor VIII in hemophilia A patients. Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950 [TBL] [Abstract][Full Text] [Related]
15. The management of bleeding in hemophilia. Abildgaard CF Adv Pediatr; 1969; 16():365-90. PubMed ID: 4899062 [No Abstract] [Full Text] [Related]
16. Clinical experience with transfusions of FI-O-Ta. Pavlovsky A; De Tezanos Pinto M; Canaveri M Thromb Diath Haemorrh Suppl; 1967; 26():383-90. PubMed ID: 5299606 [No Abstract] [Full Text] [Related]
17. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG]. Foltyn H; Wróbel I Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502 [No Abstract] [Full Text] [Related]
18. [Inhibitors suppression in hemophilia A with continued treatment of factor VIII]. Aznar JA; Jiménez C; García I; Martín G; Borrego D; Peiro A; Marty ML Sangre (Barc); 1982; 27(4A):572. PubMed ID: 6818701 [No Abstract] [Full Text] [Related]
19. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A]. Gaerisch F; Stein P Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530 [TBL] [Abstract][Full Text] [Related]
20. [Preparation and use of factor VIII concentrates in hemophilia]. Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112 [No Abstract] [Full Text] [Related] [Next] [New Search]